Skip to main content
SpringerLink
Log in

Implementation of a Pharmacist-Led Clinic for Hypertensive Patients in Primary Care – A Pilot Study

  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

Abstract

Objectives:To implement a pharmacist-led Hypertension Management Clinic in one general medical practice. To evaluate the impact of the clinic on blood pressure (BP) control and prevention of coronary heart disease (CHD). Method:A total of 242 patients attended the pharmacist-led hypertension clinic over a 10-month period. Lifestyle and drug therapy alterations were implemented to achieve British Hypertension Society (BHS) target level BP. A sub-group of 160 patients were used to compare BP control in the clinic setting against that with the general practitioner (GP). Assessment was made of 10-year CHD risk in patients with no artherosclerotic disease. Patients with underlying artherosclerotic disease were prescribed statins, and antiplatelet drugs where indicated. Main outcome measures:Changes in numbers of hypertensive patients meeting the BHS target level BP. Changes in prescribing of antiplatelet agents and statins for primary and secondary prevention of artherosclerosis. Results:In 206 patients with established hypertension, the number achieving target level BPs increased from 74 (36%) pre-clinic to 174 (85%) post-clinic; P < 0.001 chi-squared test. After attending the clinic, for 5 months 74 patients (80%) achieved target level BP in the clinic compared with 27 (40%) with standard GP care; P < 0.001 chi-squared test. Of 188 patients assessed for primary prevention therapy, 126 (67%) required treatment with aspirin and 37 (20%) with a statin. Post-clinic 101 (80%) received aspirin compared with 17 (13%) pre-clinic and 34 (92%) received a statin in comparison with 4 (11%) pre-clinic; both P < 0.001 chi-squared test.A total of 52 (96%) of 54 patients received an antiplatelet agent for secondary prevention of artherosclerosis compared with 40 patients (74%) pre-clinic. Thirty six of 54 patients required a statin for secondary prevention. Thirty five patients (97%) received a statin compared with 23 (64%) pre-clinic; both P < 0.01 chi-squared test. Conclusion:Implementation of a pharmacist-led clinic improved blood pressure control and appropriate prescribing of antiplatelet agents and statins for primary prevention of CHD and secondary prevention of artherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Le Ramsay B Williams DG Johnston et al. (1999) ArticleTitleGuidelines for the management of hypertension: report of the third working party of the British Hypertension Society J Hum Hypertens 13 569–92 Occurrence Handle10.1038/sj.jhh.1000917 Occurrence Handle10482967

    Article  PubMed  Google Scholar 

  2. D Wood P Durrington N Poulter et al. (1998) ArticleTitleJoint British recommendations on prevention of coronary heart disease in clinical practice Heart (Suppl)2 S15

    Google Scholar 

  3. J Robson K Boomla B Hart G. Feder (2000) ArticleTitleEstimating cardiovascular risk for primary prevention: outstanding questions for primary care Br Med J 320 702–4

    Google Scholar 

  4. J. Eisenberg (2000) ArticleTitleGuidelines do not consider workload implications in primary care BMJ 320 576 Occurrence Handle10.1136/bmj.320.7234.576

    Article  Google Scholar 

  5. T Marshall A. Rouse (2000) ArticleTitleGuidelines have serious weaknesses BMJ 320 576 Occurrence Handle10.1136/bmj.320.7234.576

    Article  Google Scholar 

  6. New GMS contract 2003 – Investing in general practice. London :BMJ Publications, 2003

  7. InstitutionalAuthorNameThe Life Study Group (2002) ArticleTitleCardiovascular morbidity and mortality In The Losartan Intervention For Endpoint reduction in hypertension study (LIFE) Lancet 359 995–1003

    Google Scholar 

  8. InstitutionalAuthorNameThe ALLHAT Officers and Coordinatorsforthe ALLHAT Collaborative Research Group (2002) ArticleTitleMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) J Am Med Assoc 288 2981–97

    Google Scholar 

  9. Scottish Intercollegiate Guidelines Network (SIGN) Hypertension in Older People. Edinburgh: SIGN; 2001 (SIGN Publication no. 49).

  10. InstitutionalAuthorNameThe Tone Collaborative Research Group. (1998) ArticleTitleSodium reduction and weight loss in the treatment of hypertension in older persons A randomized controlled Trial of Nonpharmacologic Interventions in the Elderly J Am Med Assoc 279 839–46

    Google Scholar 

  11. X Xin J He MG Frontini LG Ogden OI Motsamai PK. Whelton (2001) ArticleTitleEffects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials Hypertension 38 1112–7 Occurrence Handle11711507

    PubMed  Google Scholar 

  12. Brand MB, Mulcrow CD, Chiquette E et al. Dieting to control body weight for controlling hypertension in adults. The Cochrane Library Issue 3, 1999.

  13. InstitutionalAuthorNameUK Prospective diabetes study group (1998) ArticleTitleTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 703–13

    Google Scholar 

  14. A. Coca (1998) ArticleTitleActual blood pressure control: are we doing things right? J Hypertens 16 IssueIDSuppl S45–51 Occurrence Handle10.1097/00004872-199816010-00008

    Article  Google Scholar 

  15. LM. Ruilope (1995) ArticleTitleThe hidden truth: what do the clinical trials really tell us about BP control? J Hum Hypertens 9 IssueID(Suppl S3–S7

    Google Scholar 

  16. InstitutionalAuthorNameUK Prospective diabetes study group (1998) ArticleTitleTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 703–13

    Google Scholar 

  17. F Messereli BS. Mittler (1998) ArticleTitleFramingham at 50 Lancet 352 1006 Occurrence Handle10.1016/S0140-6736(05)60073-6 Occurrence Handle9759741

    Article  PubMed  Google Scholar 

  18. EJ Wallis LE Ramsay UI Haq et al. (2000) ArticleTitleCoronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population BMJ 320 671–676 Occurrence Handle10.1136/bmj.320.7236.671 Occurrence Handle10710573

    Article  PubMed  Google Scholar 

  19. R. Jackson (2000) ArticleTitleUpdated New Zealand cardiovascular disease risk benefit prediction guide BMJ 320 709–10 Occurrence Handle10.1136/bmj.320.7236.709 Occurrence Handle10710588

    Article  PubMed  Google Scholar 

  20. SR Erickson R Slaughter H. Halapy (1997) ArticleTitlePharmacists ability to influence outcomes of hypertension therapy Pharmacotherapy 17 140–7 Occurrence Handle9017775

    PubMed  Google Scholar 

  21. BL Carter DJ Barnette E Chrischilles GJ Mazzotti ZJ. Asali (1997) ArticleTitleEvaluation of hypertensive patients after care provided by community pharmacists in a rural setting Pharmacotherapy 17 1274–85 Occurrence Handle9399611

    PubMed  Google Scholar 

  22. PE Bogden RD Abbott P Williamson JK Onopa LM. Koontz (1998) ArticleTitleComparing standard care with a physician and pharmacist team approach for in controlled hypertension J Gen Intern Med 13 740–5 Occurrence Handle10.1046/j.1525-1497.1998.00225.x Occurrence Handle9824519

    Article  PubMed  Google Scholar 

  23. MP Okamoto RK. Nakahiro (2001) ArticleTitlePharmacoeconomic evaluation of a pharmacist-managed hypertension clinic Pharmacotherapy 20 1337–44 Occurrence Handle10.1592/phco.21.17.1337.34424

    Article  Google Scholar 

  24. Scottish Executive. Our National Health: A plan for action, a plan for change. Edinburgh 2000.

  25. AF Jones J Walker C Jewkes et al. (2001) ArticleTitleComparative accuracy of cardiovascular risk prediction methods in primary care patients Heart 85 37–43 Occurrence Handle10.1136/heart.85.1.37 Occurrence Handle11119458

    Article  PubMed  Google Scholar 

  26. CG Isles LD Ritchie P Murchie Risk Norrie J. (2000) ArticleTitleAssessment of primary prevention of coronary heart disease: randomised comparison of three scoring methods BMJ 320 690–1 Occurrence Handle10.1136/bmj.320.7236.690 Occurrence Handle10710579

    Article  PubMed  Google Scholar 

  27. RJ McManus J Mant M Meulendijks et al. (2002) ArticleTitleComparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study BMJ 324 459–64 Occurrence Handle10.1136/bmj.324.7335.459 Occurrence Handle11859049

    Article  PubMed  Google Scholar 

  28. CD Hepler LM. Strand (1990) ArticleTitleOpportunities and responsibilities in pharmaceutical care Am J Hosp Pharm 47 533–43 Occurrence Handle2316538

    PubMed  Google Scholar 

  29. InstitutionalAuthorNameMLX 284 (2002) Proposals for supplementary prescribing by nurses and pharmacists and proposed amendments to the prescription only medicines (human use) order 1997 Medicines Control Agency London

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacy Department, Lothian Primary Care Trust, Edinburgh, Newbyres Medical Group Midlothian and Lothian Pharmacy Academic Practice Unit, Gorebridge, UK

    Fiona Reid

  2. Pharmacy Department, Lothian Primary Care Trust, Edinburgh, and Lothian Pharmacy Academic Practice Unit, UK

    Pat Murray

  3. Midlothian Health Care Cooperative and Newbyres Medical Group, Gorebridge, Midlothian, UK

    Marion Storrie

Authors
  1. Fiona Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pat Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marion Storrie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fiona Reid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reid, F., Murray, P. & Storrie, M. Implementation of a Pharmacist-Led Clinic for Hypertensive Patients in Primary Care – A Pilot Study. Pharm World Sci 27, 202–207 (2005). https://doi.org/10.1007/s11096-004-2563-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-004-2563-y

Keywords

Search

Navigation